Mirum Pharmaceuticals, Inc. MIRM Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s change in AR?
- Mirum Pharmaceuticals, Inc. (MIRM) reported change in AR of $12.89M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s change in AR changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s change in AR decreased by 23.4% year-over-year, from $16.83M to $12.89M.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.